- Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast
- Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan
- Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event
- Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions
- Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results
- Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test
- Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Webcast
- Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for February 2024
More ▼
Key statistics
On Friday, Co-Diagnostics Inc (CODX:NAQ) closed at 1.11, 13.85% above the 52 week low of 0.975 set on May 26, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.15 |
---|---|
High | 1.18 |
Low | 1.11 |
Bid | 1.11 |
Offer | 1.17 |
Previous close | 1.14 |
Average volume | 47.60k |
---|---|
Shares outstanding | 31.26m |
Free float | 30.42m |
P/E (TTM) | -- |
Market cap | 35.64m USD |
EPS (TTM) | -1.20 USD |
Data delayed at least 15 minutes, as of Apr 26 2024 21:00 BST.
More ▼